Associated factors, emergency department visits, and hospitalization days of receiving adjunctive Chinese herbal medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan
Prolonged adjunctive CHM therapy, particularly for 181-365 days, is associated with decreased healthcare utilization among non-small cell lung cancer patients. These findings suggest a potential role for extended CHM therapy in managing NSCLC and warrant consideration by clinical teams.
Authors
- Wen‐Chen Tsai (ORCID: https://orcid.org/0000-0002-9684-0789)
- Meng-Bin Tang (ORCID: https://orcid.org/0000-0001-9483-6383)
- Wei-Yin Kuo
- Pei-Tseng Kung
Institutions
- Asia University (TW)
- China Medical University (TW)
- Chung Shan Medical University Hospital (TW)
- China Medical University Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3389/fphar.2025.1435541
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health and Welfare
- China Medical University Hospital
- China Medical University
- Division of Materials Research